Chemical Biology of Protein Arginine Modifications in Epigenetic Regulation

Chemical Reviews

Volumn 115, Issue 11, 2015, Pages 5413-5461

  Fuhrmann, Jakob ^a   Clancy, Kathleen W ^b   Thompson, Paul R ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION; ARGININE; PROTEINS;

ADP-RIBOSYLATION; ARGININE DEIMINASES; ARGININE MODIFICATION; ARGININE RESIDUE; CHEMICAL BIOLOGY; EPIGENETIC REGULATION; METHYLTRANSFERASES; POST-TRANSLATIONAL MODIFICATIONS;

CHEMICAL MODIFICATION;

ARGININE;

AMINO ACID SEQUENCE; CHEMISTRY; GENETIC EPIGENESIS; GENETICS; MOLECULAR GENETICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ARGININE; EPIGENESIS, GENETIC; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84935918229     PISSN: 00092665     EISSN: 15206890     Source Type: Journal    
DOI: 10.1021/acs.chemrev.5b00003     Document Type: Review

References (317)

1. Jenuwein, T.; Allis, C. D. Translating the histone code Science 2001, 293 (5532) 1074 - 80
2. Strahl, B. D.; Allis, C. D. The language of covalent histone modifications Nature 2000, 403 (6765) 41 - 5
3. Ruthenburg, A. J.; Allis, C. D.; Wysocka, J. Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark Mol. Cell 2007, 25 (1) 15 - 30
4. Kouzarides, T., SnapShot: histone-modifying enzymes. Cell 2007, 131 (4).
5. Arnaudo, A. M.; Garcia, B. A. Proteomic characterization of novel histone post-translational modifications Epigenet. Chromatin 2013, 6 (1) 24
6. Tan, M.; Luo, H.; Lee, S.; Jin, F.; Yang, J. S.; Montellier, E.; Buchou, T.; Cheng, Z.; Rousseaux, S.; Rajagopal, N.; Lu, Z.; Ye, Z.; Zhu, Q.; Wysocka, J.; Ye, Y.; Khochbin, S.; Ren, B.; Zhao, Y. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification Cell 2011, 146 (6) 1016 - 28
7. Luger, K.; Mader, A. W.; Richmond, R. K.; Sargent, D. F.; Richmond, T. J. Crystal structure of the nucleosome core particle at 2.8 angstrom resolution Nature 1997, 389 (6648) 251 - 260
8. Lee, W.; Tillo, D.; Bray, N.; Morse, R. H.; Davis, R. W.; Hughes, T. R.; Nislow, C. A high-resolution atlas of nucleosome occupancy in yeast Nat. Genet. 2007, 39 (10) 1235 - 1244
9. Valouev, A.; Johnson, S. M.; Boyd, S. D.; Smith, C. L.; Fire, A. Z.; Sidow, A. Determinants of nucleosome organization in primary human cells Nature 2011, 474 (7352) 516 - U148
10. Pray, L. At the flick of a switch: epigenetic drugs Chem. Biol. 2008, 15 (7) 640 - 641
11. Copeland, R. A.; Solomon, M. E.; Richon, V. M. Protein methyltransferases as a target class for drug discovery Nat. Rev. Drug Discovery 2009, 8 (9) 724 - 732
12. Khan, O.; La Thangue, N. B. HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications Immunol. Cell Biol. 2012, 90 (1) 85 - 94
13. Jencks, W. P.; Regenstein, J. Ionization Constants of Acids and Bases. In Handbook of Biochemistry and Molecular Biology, 4 th ed.; CRC Press: Boca Raton, FL, 2010; pp 595 - 635.
14. Luscombe, N. M.; Laskowski, R. A.; Thornton, J. M. Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level Nucleic Acids Res. 2001, 29 (13) 2860 - 74
15. Calnan, B. J.; Tidor, B.; Biancalana, S.; Hudson, D.; Frankel, A. D. Arginine-mediated RNA recognition: the arginine fork Science 1991, 252 (5009) 1167 - 71
16. Mandell, D. J.; Chorny, I.; Groban, E. S.; Wong, S. E.; Levine, E.; Rapp, C. S.; Jacobson, M. P. Strengths of hydrogen bonds involving phosphorylated amino acid side chains J. Am. Chem. Soc. 2007, 129 (4) 820 - 7
17. Bannister, A. J.; Kouzarides, T. Regulation of chromatin by histone modifications Cell Res. 2011, 21 (3) 381 - 95
18. Vossenaar, E. R.; Zendman, A. J.; van Venrooij, W. J.; Pruijn, G. J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease BioEssays 2003, 25 (11) 1106 - 18
19. Hirofumi, T.; Tomoharu, G.; Bryan, K.; Paul R, T.; Oliver, V.; Kazuya, H.; Tatsurou, M.; Kouichiro, S.; Hiroyuki, H.; Eiji, S. Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms Adv. Biosci. Biotechnol. 2011, 2 (4) 304 - 310
20. Nakashima, K.; Hagiwara, T.; Ishigami, A.; Nagata, S.; Asaga, H.; Kuramoto, M.; Senshu, T.; Yamada, M. Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3) J. Biol. Chem. 1999, 274 (39) 27786 - 92
21. Guerrin, M.; Ishigami, A.; Mechin, M. C.; Nachat, R.; Valmary, S.; Sebbag, M.; Simon, M.; Senshu, T.; Serre, G. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I Biochem. J. 2003, 370, 167 - 174
22. Ishigami, A.; Ohsawa, T.; Asaga, H.; Akiyama, K.; Kuramoto, M.; Maruyama, N. Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin Arch. Biochem. Biophys. 2002, 407 (1) 25 - 31
23. Kanno, T.; Kawada, A.; Yamanouchi, J.; Yosida-Noro, C.; Yoshiki, A.; Shiraiwa, M.; Kusakabe, M.; Manabe, M.; Tezuka, T.; Takahara, H. Human peptidylarginine deiminase type III: Molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin J. Invest. Dermatol. 2000, 115 (5) 813 - 823
24. Chavanas, S.; Mechin, M. C.; Takahara, H.; Kawada, A.; Nachat, R.; Serre, G.; Simon, M. Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6 Gene 2004, 330, 19 - 27
25. Wright, P. W.; Bolling, L. C.; Calvert, M. E.; Sarmento, O. F.; Berkeley, E. V.; Shea, M. C.; Hao, Z. L.; Jayes, F. C.; Bush, L. A.; Shetty, J.; Shore, A. N.; Reddi, P. P.; Tung, K. S.; Samy, E.; Allietta, M. M.; Sherman, N. E.; Herr, J. C.; Coonrod, S. A. ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets Dev. Biol. 2003, 256 (1) 73 - 88
26. Nakashima, K.; Hagiwara, T.; Yamada, M. Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes J. Biol. Chem. 2002, 277 (51) 49562 - 49568
27. Cherrington, B. D.; Morency, E.; Struble, A. M.; Coonrod, S. A.; Wakshlag, J. J. Potential Role for Peptidylarginine Deiminase 2 (PAD2) in Citrullination of Canine Mammary Epithelial Cell Histones PLoS One 2010, 5 (7) e11768
28. Jang, B.; Shin, H. Y.; Choi, J. K.; Du, P. T. N.; Jeong, B. H.; Ishigami, A.; Maruyama, N.; Carp, R. I.; Kim, Y. S.; Choi, E. K. Subcellular Localization of Peptidylarginine Deiminase 2 and Citrullinated Proteins in Brains of Scrapie-Infected Mice: Nuclear Localization of PAD2 and Membrane Fraction-Enriched Citrullinated Proteins J. Neuropathol. Exp. Neurol. 2011, 70 (2) 116 - 124
29. Shirai, H.; Blundell, T. L.; Mizuguchi, K. A novel superfamily of enzymes that catalyze the modification of guanidino groups Trends Biochem. Sci. 2001, 26 (8) 465 - 468
30. Shirai, H.; Mokrab, Y.; Mizuguchi, K. The guanidino-group modifying enzymes: structural basis for their diversity and commonality Proteins 2006, 64 (4) 1010 - 1023
31. Linsky, T.; Fast, W. Mechanistic similarity and diversity among the guanidine-modifying members of the pentein superfamily Biochim. Biophys. Acta, Proteins Proteomics 2010, 1804 (10) 1943 - 1953
32. Kearney, P. L.; Bhatia, M.; Jones, N. G.; Yuan, L.; Glascock, M. C.; Catchings, K. L.; Yamada, M.; Thompson, P. R. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis Biochemistry 2005, 44 (31) 10570 - 10582
33. Lewis, C. A.; Wolfenden, R. The Nonenzymatic Decomposition of Guanidines and Amidines J. Am. Chem. Soc. 2014, 136 (1) 130 - 136
34. 2+-induced activation of human PAD4 Nat. Struct. Mol. Biol. 2004, 11 (8) 777 - 783
35. Liu, Y. L.; Chiang, Y. H.; Liu, G. Y.; Hung, H. C. Functional Role of Dimerization of Human Peptidylarginine Deiminase 4 (PAD4) PLoS One 2011, 6 (6) e21314
36. Slade, D. J.; Fang, P.; Dreyton, C. J.; Zhang, Y.; Fuhrmann, J.; Rempel, D.; Bax, B. D.; Coonrod, S. A.; Lewis, H. D.; Guo, M.; Gross, M. L.; Thompson, P. R. Protein Arginine Deiminase 2 Binds Calcium in an Ordered Fashion: Implications for Inhibitor Design ACS Chem. Biol. 2015, 10 (4) 1043 - 1053
37. Tour, O.; Adams, S. R.; Kerr, R. A.; Meijer, R. M.; Sejnowski, T. J.; Tsien, R. W.; Tsien, R. Y. Calcium Green FlAsH as a genetically targeted small-molecule calcium indicator Nat. Chem. Biol. 2007, 3 (7) 423 - 431
38. Darrah, E.; Giles, J. T.; Ols, M. L.; Bull, H. G.; Andrade, F.; Rosen, A., Erosive Rheumatoid Arthritis Is Associated with Antibodies That Activate PAD4 by Increasing Calcium Sensitivity. Sci. Transl. Med. 2013, 5 (186).
39. Murray-Rust, J.; Leiper, J.; McAlister, M.; Phelan, J.; Tilley, S.; Maria, J. S.; Vallance, P.; McDonald, N. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase Nat. Struct. Mol. Biol. 2001, 8 (8) 679 - 683
40. Das, K.; Butler, G. H.; Kwiatkowski, V.; Clark, A. D.; Yadav, P.; Arnold, E. Crystal structures of arginine deiminase with covalent reaction intermediates: Implications for catalytic mechanism Structure 2004, 12 (4) 657 - 667
41. Linsky, T. W.; Fast, W., Guanidine-Modifying Enzymes in the Pentein Superfamily. Comprehensive Natural Products Chemistry II, Chemistry and Biology; Elsevier: Amsterdam, 2010; Vol. 8, pp 125 - 159.
42. Frey, D.; Braun, O.; Briand, C.; Vasak, M.; Grutter, M. G. Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: a basis for the design of specific inhibitors Structure 2006, 14 (5) 901 - 911
43. Thompson, P. R.; Fast, W. Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock? ACS Chem. Biol. 2006, 1 (7) 433 - 441
44. Teo, C. Y.; Shave, S.; Chor, A. L. T.; Salleh, A.; Rahman, M. B. B.; Walkinshaw, M. D.; Tejo, B. A., Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening. BMC Bioinf. 2012, 13.
45. Causey, C. P.; Jones, J. E.; Slack, J. L.; Kamei, D.; Jones, L. E.; Subramanian, V.; Knuckley, B.; Ebrahimi, P.; Chumanevich, A. A.; Luo, Y.; Hashimoto, H.; Sato, M.; Hofseth, L. J.; Thompson, P. R. The Development of N -α-(2-Carboxyl)benzoyl- N -5-(2-fluoro-1-iminoethyl)- l -ornithine Amide (o -F-amidine) and N -α-(2-Carboxyl)benzoyl- N -5-(2-chloro-1-iminoethyl)- l -ornithine Amide (o -Cl-amidine) as Second Generation Protein Arginine Deiminase (PAD) Inhibitors J. Med. Chem. 2011, 54 (19) 6919 - 6935
46. Slack, J. L.; Jones, L. E.; Bhatia, M. M.; Thompson, P. R. Autodeimination of Protein Arginine Deiminase 4 Alters Protein-Protein Interactions but Not Activity Biochemistry 2011, 50 (19) 3997 - 4010
47. Arita, K.; Shimizu, T.; Hashimoto, H.; Hidaka, Y.; Yamada, M.; Sato, M. Structural basis for histone N-terminal recognition by human peptidylarginine deiminase 4 Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (14) 5291 - 5296
48. Khorasanizadeh, S. The nucleosome: from genomic organization to genomic regulation Cell 2004, 116 (2) 259 - 272
49. Knuckley, B.; Bhatia, M.; Thompson, P. R. Protein arginine deiminase 4: evidence for a reverse protonation mechanism Biochemistry 2007, 46 (22) 6578 - 87
50. Knuckley, B.; Causey, C. P.; Jones, J. E.; Bhatia, M.; Dreyton, C. J.; Osborne, T. C.; Takahara, H.; Thompson, P. R. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3 Biochemistry 2010, 49 (23) 4852 - 63
51. Fujisaki, M.; Sugawara, K. Properties of peptidylarginine deiminase from the epidermis of newborn rats J. Biochem. 1981, 89 (1) 257 - 63
52. Luo, Y.; Arita, K.; Bhatia, M.; Knuckley, B.; Lee, Y. H.; Stallcup, M. R.; Sato, M.; Thompson, P. R. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization Biochemistry 2006, 45 (39) 11727 - 11736
53. Jones, J. E.; Slack, J. L.; Fang, P. F.; Zhang, X. S.; Subramanian, V.; Causey, C. P.; Coonrod, S. A.; Guo, M.; Thompson, P. R. Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective Inhibitors ACS Chem. Biol. 2012, 7 (1) 160 - 165
54. Dreyton, C. J.; Knuckley, B.; Jones, J. E.; Lewallen, D. M.; Thompson, P. R. Mechanistic Studies of Protein Arginine Deiminase 2: Evidence for a Substrate-Assisted Mechanism Biochemistry 2014, 53 (27) 4426 - 4433
55. Stone, E. M.; Costello, A. L.; Tierney, D. L.; Fast, W. Substrate-assisted cysteine deprotonation in the mechanism of dimethylargininase (DDAH) from Pseudomonas aeruginosa Biochemistry 2006, 45 (17) 5618 - 5630
56. Wang, Y.; Wysocka, J.; Sayegh, J.; Lee, Y. H.; Perlin, J. R.; Leonelli, L.; Sonbuchner, L. S.; McDonald, C. H.; Cook, R. G.; Dou, Y.; Roeder, R. G.; Clarke, S.; Stallcup, M. R.; Allis, C. D.; Coonrod, S. A. Human PAD4 regulates histone arginine methylation levels via demethylimination Science 2004, 306 (5694) 279 - 283
57. Hidaka, Y.; Hagiwara, T.; Yamada, M. Methylation of the guanidino group of arginine residues prevents citrullination by peptidylarginine deiminase IV FEBS Lett. 2005, 579 (19) 4088 - 4092
58. Raijmakers, R.; Zendman, A. J. W.; Egberts, W. V.; Vossenaar, E. R.; Raats, J.; Soede-Huijbregts, C.; Rutjes, F. P. J. T.; van Veelen, P. A.; Drijfhout, J. W.; Pruijn, G. J. M. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro J. Mol. Biol. 2007, 367 (4) 1118 - 1129
59. Lluis, M.; Wang, Y.; Monzingo, A. F.; Fast, W.; Robertus, J. D. Characterization of C-Alkyl Amidines as Bioavailable Covalent Reversible Inhibitors of Human DDAH-1 ChemMedChem 2011, 6 (1) 81 - 88
60. Cuthbert, G. L.; Daujat, S.; Snowden, A. W.; Erdjument-Bromage, H.; Hagiwara, T.; Yamada, M.; Schneider, R.; Gregory, P. D.; Tempst, P.; Bannister, A. J.; Kouzarides, T. Histone deimination antagonizes arginine methylation Cell 2004, 118 (5) 545 - 553
61. Allis, C. D.; Bowen, J. K.; Abraham, G. N.; Glover, C. V. C.; Gorovsky, M. A. Proteolytic Processing of Histone-H3 in Chromatin-a Physiologically Regulated Event in Tetrahymena Micronuclei Cell 1980, 20 (1) 55 - 64
62. Jin, J. J.; Cai, Y.; Li, B.; Conaway, R. C.; Workman, J. L.; Conaway, J. W.; Kusch, T. In and out: histone variant exchange in chromatin Trends Biochem. Sci. 2005, 30 (12) 680 - 687
63. Bannister, A. J.; Schneider, R.; Kouzarides, T. Histone methylation: dynamic or static? Cell 2002, 109 (7) 801 - 806
64. Wu, C. Y.; Lee, H. J.; Wu, S. H.; Chen, S. T.; Chiou, S. H.; Chang, G. G. Chemical mechanism of the endogenous argininosuccinate lyase activity of duck lens delta2-crystallin Biochem. J. 1998, 333, 327 - 334
65. Goto, M.; Omi, R.; Miyahara, I.; Sugahara, M.; Hirotsu, K. Structures of argininosuccinate synthetase in enzyme-ATP substrates and enzyme-AMP product forms-stereochemistry of the catalytic reaction J. Biol. Chem. 2003, 278 (25) 22964 - 22971
66. Sampaleanu, L. M.; Codding, P. W.; Lobsanov, Y. D.; Tsai, M.; Smith, G. D.; Horvatin, C.; Howell, P. L. Structural studies of duck δ2 crystallin mutants provide insight into the role of Thr(161) and the 280s loop in catalysis Biochem. J. 2004, 384, 437 - 447
67. Morris, S. M. Regulation of enzymes of the urea cycle and arginine metabolism Annu. Rev. Nutr. 2002, 22, 87 - 105
68. Pritzker, L. B.; Moscarello, M. A. A novel microtubule independent effect of paclitaxel: the inhibition of peptidylarginine deiminase from bovine brain Biochim. Biophys. Acta, Protein Struct. Mol. Enzymol. 1998, 1388 (1) 154 - 160
69. Knuckley, B.; Luo, Y.; Thompson, P. R. Profiling protein arginine deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors Bioorg. Med. Chem. 2008, 16 (2) 739 - 745
70. Bozdag, M.; Dreker, T.; Henry, C.; Tosco, P.; Vallaro, M.; Fruttero, R.; Scozzafava, A.; Carta, F.; Supuran, C. T. Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors Bioorg. Med. Chem. Lett. 2013, 23 (3) 715 - 719
71. Ferretti, P.; Pong, U. K.; Vagaska, B.; Merchant, R.; Matthews, C. J.; Marson, C. M. Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase MedChemComm 2013, 4 (7) 1109 - 1113
72. 2 Receptor Agonists J. Med. Chem. 2008, 51 (22) 7193 - 7204
73. Lewallen, D. M.; Bicker, K. L.; Madoux, F.; Chase, P.; Anguish, L.; Coonrod, S.; Hodder, P.; Thompson, P. R. A FluoPol-ABPP PAD2 High-Throughput Screen Identifies the First Calcium Site Inhibitor Targeting the PADs ACS Chem. Biol. 2014, 9 (4) 913 - 921
74. Lewis, H. D.; Liddle, J.; Coote, J. E.; Atkinson, S. J.; Barker, M. D.; Bax, B. D.; Bicker, K. L.; Bingham, R. P.; Campbell, M.; Chen, Y. H.; Chung, C. W.; Craggs, P. D.; Davis, R. P.; Eberhard, D.; Joberty, G.; Lind, K. E.; Locke, K.; Maller, C.; Martinod, K.; Patten, C.; Polyakova, O.; Rise, C. E.; Rudiger, M.; Sheppard, R. J.; Slade, D. J.; Thomas, P.; Thorpe, J.; Yao, G.; Drewes, G.; Wagner, D. D.; Thompson, P. R.; Prinjha, R. K.; Wilson, D. M. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation Nat. Chem. Biol. 2015, 11 (3) 189 - 91
75. Stone, E. M.; Schaller, T. H.; Bianchi, H.; Person, M. D.; Fast, W. Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase Biochemistry 2005, 44 (42) 13744 - 13752
76. Luo, Y.; Knuckley, B.; Lee, Y. H.; Stallcup, M. R.; Thompson, P. R. A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation J. Am. Chem. Soc. 2006, 128 (4) 1092 - 1093
77. Knuckley, B.; Causey, C. P.; Pellechia, P. J.; Cook, P. F.; Thompson, P. R. Haloacetamidine-Based Inactivators of Protein Arginine Deiminase 4 (PAD4): Evidence that General Acid Catalysis Promotes Efficient Inactivation ChemBioChem 2010, 11 (2) 161 - 165
78. Li, D.; Liu, C.; Lin, J. Theoretical study of the mechanism of protein arginine deiminase 4 (PAD4) inhibition by F-amidine J. Mol. Graphics Modell. 2015, 55, 25 - 32
79. Bicker, K. L.; Anguish, L.; Chumanevich, A. A.; Cameron, M. D.; Cui, X. L.; Witalison, E.; Subramanian, V.; Zhang, X. S.; Chumanevich, A. P.; Hofseth, L. J.; Coonrod, S. A.; Thompson, P. R. d -Amino Acid-Based Protein Arginine Deiminase Inhibitors: Synthesis, Pharmacokinetics, and in Cellulo Efficacy ACS Med. Chem. Lett. 2012, 3 (12) 1081 - 1085
80. Nomura, K. Specificity and Mode of Action of the Muscle-Type Protein-Arginine Deiminase Arch. Biochem. Biophys. 1992, 293 (2) 362 - 369
81. Wang, Y. J.; Li, P. X.; Wang, S.; Hu, J.; Chen, X. A.; Wu, J. H.; Fisher, M.; Oshaben, K.; Zhao, N.; Gu, Y.; Wang, D.; Chen, G.; Wang, Y. M. Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity J. Biol. Chem. 2012, 287 (31) 25941 - 25953
82. Knight, J. S.; Subramanian, V.; O'Dell, A. A.; Yalavarthi, S.; Zhao, W.; Smith, C. K.; Hodgin, J. B.; Thompson, P. R.; Kaplan, M. J. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann. Rheum. Dis. 2014, DOI: 10.1136/annrheumdis-2014-205365.
83. Luo, Y.; Knuckley, B.; Bhatia, M.; Pellechia, P. J.; Thompson, P. R. Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe J. Am. Chem. Soc. 2006, 128 (45) 14468 - 14469
84. Slack, J. L.; Causey, C. P.; Luo, Y.; Thompson, P. R. Development and Use of Clickable Activity Based Protein Profiling Agents for Protein Arginine Deiminase 4 ACS Chem. Biol. 2011, 6 (5) 466 - 476
85. Knuckley, B.; Jones, J. E.; Bachovchin, D. A.; Slack, J.; Causey, C. P.; Brown, S. J.; Rosen, H.; Cravatt, B. F.; Thompson, P. R.; fluopol-ABPP, A. HTS assay to identify PAD inhibitors Chem. Commun. (Cambridge, U.K.) 2010, 46 (38) 7175 - 7177
86. Dreyton, C. J.; Anderson, E. D.; Subramanian, V.; Boger, D. L.; Thompson, P. R. Insights into the mechanism of streptonigrin-induced protein arginine deiminase inactivation Bioorg. Med. Chem. 2014, 22 (4) 1362 - 1369
87. Hagiwara, T.; Hidaka, Y.; Yamada, M. Deimination of histone H2A and H4 at arginine 3 in HL-60 granulocytes Biochemistry 2005, 44 (15) 5827 - 5834
88. Zhang, X. S.; Bolt, M.; Guertin, M. J.; Chen, W.; Zhang, S.; Cherrington, B. D.; Slade, D. J.; Dreyton, C. J.; Subramanian, V.; Bicker, K. L.; Thompson, P. R.; Mancini, M. A.; Lis, J. T.; Coonrod, S. A. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor alpha target gene activation Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (33) 13331 - 13336
89. Li, P. X.; Yao, H. J.; Zhang, Z. Q.; Li, M.; Luo, Y.; Thompson, P. R.; Gilmour, D. S.; Wang, Y. M. Regulation of p53 target gene expression by peptidylarginine deiminase 4 Mol. Cell. Biol. 2008, 28 (15) 4745 - 4758
90. Li, P.; Wang, D.; Yao, H.; Doret, P.; Hao, G.; Shen, Q.; Qiu, H.; Zhang, X.; Wang, Y.; Chen, G.; Wang, Y. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression Oncogene 2010, 29 (21) 3153 - 3162
91. Yao, H.; Li, P.; Venters, B. J.; Zheng, S.; Thompson, P. R.; Pugh, B. F.; Wang, Y. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis J. Biol. Chem. 2008, 283 (29) 20060 - 8
92. Sharma, P.; Azebi, S.; England, P.; Christensen, T.; M?ller-Larsen, A.; Petersen, T.; Batsche, E.; Muchardt, C., Citrullination of Histone H3 Interferes with HP1-Mediated Transcriptional Repression. PLoS Genet. 2012, 8 (9).
93. Kolodziej, S.; Kuvardina, O. N.; Oellerich, T.; Herglotz, J.; Backert, I.; Kohrs, N.; Buscato, E.; Wittmann, S. K.; Salinas-Riester, G.; Bonig, H.; Karas, M.; Serve, H.; Proschak, E.; Lausen, J., PADI4 acts as a coactivator of Tal1 by counteracting repressive histone arginine methylation. Nat. Commun. 2014, 5.
94. Christophorou, M. A.; Castelo-Branco, G.; Halley-Stott, R. P.; Oliveira, C. S.; Loos, R.; Radzisheuskaya, A.; Mowen, K. A.; Bertone, P.; Silva, J. C. R.; Zernicka-Goetz, M.; Nielsen, M. L.; Gurdon, J. B.; Kouzarides, T. Citrullination regulates pluripotency and histone H1 binding to chromatin Nature 2014, 507 (7490) 104 - 108
95. Slade, D. J.; Subramanian, V.; Thompson, P. R. Pluripotency: citrullination unravels stem cells Nat. Chem. Biol. 2014, 10 (5) 327 - 8
96. Dwivedi, N.; Neeli, I.; Schall, N.; Wan, H.; Desiderio, D. M.; Csernok, E.; Thompson, P. R.; Dali, H.; Briand, J. P.; Muller, S.; Radic, M. Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity FASEB J. 2014, 28 (7) 2840 - 2851
97. Guertin, M. J.; Zhang, X.; Anguish, L.; Kim, S.; Varticovski, L.; Lis, J. T.; Hager, G. L.; Coonrod, S. A. Targeted H3R26 deimination specifically facilitates estrogen receptor binding by modifying nucleosome structure PLoS Genet. 2014, 10 (9) e1004613
98. Zhang, X. S.; Gamble, M. J.; Stadler, S.; Cherrington, B. D.; Causey, C. P.; Thompson, P. R.; Roberson, M. S.; Kraus, W. L.; Coonrod, S. A., Genome-Wide Analysis Reveals PADI4 Cooperates with Elk-1 To Activate c-Fos Expression in Breast Cancer Cells. PLoS Genet. 2011, 7 (6).
99. Andrade, F.; Darrah, E.; Gucek, M.; Cole, R. N.; Rosen, A.; Zhu, X. M. Autocitrullination of Human Peptidyl Arginine Deiminase Type 4 Regulates Protein Citrullination during Cell Activation Arthritis Rheum. 2010, 62 (6) 1630 - 1640
100. Tanikawa, C.; Espinosa, M.; Suzuki, A.; Masuda, K.; Yamamoto, K.; Tsuchiya, E.; Ueda, K.; Daigo, Y.; Nakamura, Y.; Matsuda, K. Regulation of histone modification and chromatin structure by the p53-PADI4 pathway. Nat. Commun. 2012, 3, No. 676.
101. Tanikawa, C.; Ueda, K.; Nakagawa, H.; Yoshida, N.; Nakamura, Y.; Matsuda, K. Regulation of Protein Citrullination through p53/PAD14 Network in DNA Damage Response Cancer Res. 2009, 69 (22) 8761 - 8769
102. Hemmers, S.; Teijaro, J. R.; Arandjelovic, S.; Mowen, K. A. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection PLoS One 2011, 6 (7) e22043
103. Neeli, I.; Khan, S. N.; Radic, M. Histone deimination as a response to inflammatory stimuli in neutrophils J. Immunol. 2008, 180 (3) 1895 - 1902
104. Li, P. X.; Li, M.; Lindberg, M. R.; Kennett, M. J.; Xiong, N.; Wang, Y. M. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps J. Exp. Med. 2010, 207 (9) 1853 - 1862
105. Wang, Y. M.; Li, M.; Stadler, S.; Correll, S.; Li, P. X.; Wang, D. C.; Hayama, R.; Leonelli, L.; Han, H.; Grigoryev, S. A.; Allis, C. D.; Coonrod, S. A. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation J. Cell Biol. 2009, 184 (2) 205 - 213
106. Khandpur, R.; Carmona-Rivera, C.; Vivekanandan-Giri, A.; Gizinski, A.; Yalavarthi, S.; Knight, J. S.; Friday, S.; Li, S.; Patel, R. M.; Subramanian, V.; Thompson, P.; Chen, P. J.; Fox, D. A.; Pennathur, S.; Kaplan, M. J., NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis. Sci. Transl. Med. 2013, 5 (178).
107. Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D. S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil extracellular traps kill bacteria Science 2004, 303 (5663) 1532 - 1535
108. Hirsch, J. G. Bactericidal Action of Histone J. Exp. Med. 1958, 108 (6) 925 - 944
109. Knight, J. S.; Zhao, W. P.; Luo, W.; Subramanian, V.; O'Dell, A. A.; Yalavarthi, S.; Hodgin, J. B.; Eitzman, D. T.; Thompson, P. R.; Kaplan, M. J. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus J. Clin. Invest. 2013, 123 (7) 2981 - 2993
110. Knight, J. S.; Luo, W.; O'Dell, A. A.; Yalavarthi, S.; Zhao, W. P.; Subramanian, V.; Guo, C. A.; Grenn, R. C.; Thompson, P. R.; Eitzman, D. T.; Kaplan, M. J. Peptidylarginine Deiminase Inhibition Reduces Vascular Damage and Modulates Innate Immune Responses in Murine Models of Atherosclerosis Circ. Res. 2014, 114 (6) 947 - 956
111. Bicker, K. L.; Thompson, P. R. The protein arginine deiminases: structure, function, inhibition, and disease Biopolymers 2013, 99 (2) 155 - 63
112. Wang, S.; Wang, Y. M. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis Biochim. Biophys. Acta, Gene Regul. Mech. 2013, 1829 (10) 1126 - 1135
113. Gyorgy, B.; Toth, E.; Tarcsa, E.; Falus, A.; Buzas, E. I. Citrullination: a posttranslational modification in health and disease Int. J. Biochem. Cell Biol. 2006, 38 (10) 1662 - 1677
114. Jones, J. E.; Causey, C. P.; Knuckley, B.; Slack-Noyes, J. L.; Thompson, P. R. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential Curr. Opin. Drug Discovery Dev. 2009, 12 (5) 616 - 627
115. Esteller, M. Molecular origins of cancer: epigenetics in cancer N. Engl. J. Med. 2008, 358 (11) 1148 - 1159
116. Chi, P.; Allis, C. D.; Wang, G. G. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers Nat. Rev. Cancer 2010, 10 (7) 457 - 469
117. Chang, X. T.; Han, J. X. Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors Mol. Carcinog. 2006, 45 (3) 183 - 196
118. Chang, X. T.; Han, J. X.; Pang, L.; Zhao, Y.; Yang, Y.; Shen, Z. L., Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 2009, 9;.
119. Wang, L.; Chang, X. T.; Yuan, G. Y.; Zhao, Y.; Wang, P. C. Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors Int. J. Biol. Sci. 2010, 6 (5) 454 - 464
120. Hollstein, M.; Sidransky, D.; Vogelstein, B.; Harris, C. C. P53 Mutations in Human Cancers Science 1991, 253 (5015) 49 - 53
121. Levine, A. J.; Momand, J.; Finlay, C. A. The P53 Tumor Suppressor Gene Nature 1991, 351 (6326) 453 - 456
122. Vogelstein, B.; Lane, D.; Levine, A. J. Surfing the p53 network Nature 2000, 408 (6810) 307 - 310
123. Slack, J. L.; Causey, C. P.; Thompson, P. R. Protein arginine deiminase 4: a target for an epigenetic cancer therapy Cell. Mol. Life Sci. 2011, 68 (4) 709 - 20
124. McElwee, J. L.; Mohanan, S.; Griffith, O. L.; Breuer, H. C.; Anguish, L. J.; Cherrington, B. D.; Palmer, A. M.; Howe, L. R.; Subramanian, V.; Causey, C. P.; Thompson, P. R.; Gray, J. W.; Coonrod, S. A. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer 2012, 12, No. 500.
125. Suzuki, A.; Yamada, R.; Chang, X.; Tokuhiro, S.; Sawada, T.; Suzuki, M.; Nagasaki, M.; Nakayama-Hamada, M.; Kawaida, R.; Ono, M.; Ohtsuki, M.; Furukawa, H.; Yoshino, S.; Yukioka, M.; Tohma, S.; Matsubara, T.; Wakitani, S.; Teshima, R.; Nishioka, Y.; Sekine, A.; Iida, A.; Takahashi, A.; Tsunoda, T.; Nakamura, Y.; Yamamoto, K. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat. Genet. 2003, 34 (4) 395 - 402
126. Aletaha, D.; Neogi, T.; Silman, A. J.; Funovits, J.; Felson, D. T.; Bingham, C. O.; Birnbaum, N. S.; Burmester, G. R.; Bykerk, V. P.; Cohen, M. D.; Combe, B.; Costenbader, K. H.; Dougados, M.; Emery, P.; Ferraccioli, G.; Hazes, J. M. W.; Hobbs, K.; Huizinga, T. W. J.; Kavanaugh, A.; Kay, J.; Kvien, T. K.; Laing, T.; Mease, P.; Menard, H. A.; Moreland, L. W.; Naden, R. L.; Pincus, T.; Smolen, J. S.; Stanislawska-Biernat, E.; Symmons, D.; Tak, P. P.; Upchurch, K. S.; Vencovsky, J.; Wolfe, F.; Hawker, G. 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Arthritis Rheum. 2010, 62 (9) 2569 - 2581
127. Schellekens, G. A.; Visser, H.; de Jong, B. A. W.; Van den Hoogen, F. H. J.; Hazes, J. M. W.; Breedveld, F. C.; van Venrooij, W. J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum. 2000, 43 (1) 155 - 163
128. Machold, K. P.; Stamm, T. A.; Nell, V. P. K.; Pflugbeil, S.; Aletaha, D.; Steiner, G.; Uffmann, M.; Smolen, J. S. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease Rheumatology 2007, 46 (2) 342 - 349
129. Willis, V.; Gizinski, A. M.; Banda, N. K.; Causey, C. P.; Knuckley, B.; Cordova, K. N.; Luo, Y. A.; Levitt, B.; Glogowska, M.; Chandra, P.; Kulik, L.; Robinson, W. H.; Arend, W. P.; Thompson, P. R.; Holers, V. M. N-α-Benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis J. Immunol. 2011, 186 (7) 4396 - 4404
130. Chumanevich, A. A.; Causey, C. P.; Knuckley, B. A.; Jones, J. E.; Poudyal, D.; Chumanevich, A. P.; Davis, T.; Matesic, L. E.; Thompson, P. R.; Hofseth, L. J. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300 (6) G929 - G938
131. Elkon, K. B.; Wiedeman, A. Type I IFN system in the development and manifestations of SLE Curr. Opin. Rheumatol. 2012, 24 (5) 499 - 505
132. Martinod, K.; Demers, M.; Fuchs, T. A.; Wong, S. L.; Brill, A.; Gallant, M.; Hu, J.; Wang, Y. M.; Wagner, D. D. Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (21) 8674 - 8679
133. Savchenko, A. S.; Borissoff, J. I.; Martinod, K.; De Meyer, S. F.; Gallant, M.; Erpenbeck, L.; Brill, A.; Wang, Y. M.; Wagner, D. D. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice Blood 2014, 123 (1) 141 - 148
134. Zheng, X. L. DNase, ADAMTS13, and iPAD4: good for the heart Blood 2014, 123 (1) 10 - 11
135. Martinod, K.; Wagner, D. D. Thrombosis: tangled up in NETs Blood 2014, 123 (18) 2768 - 2776
136. Wood, D. D.; Bilbao, J. M.; OConnors, P.; Moscarello, M. A. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein Ann. Neurol. 1996, 40 (1) 18 - 24
137. Mastronardi, F. G.; Mak, B.; Ackerley, C. A.; Roots, B. I.; Moscarello, M. A. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis J. Clin. Invest. 1996, 97 (2) 349 - 358
138. Moscarello, M. A.; Pritzker, L.; Mastronardi, F. G.; Wood, D. D. Peptidylarginine deiminase: a candidate factor in demyelinating disease J. Neurochem. 2002, 81 (2) 335 - 343
139. Musse, A. A.; Li, Z.; Ackerley, C. A.; Bienzle, D.; Lei, H.; Poma, R.; Harauz, G.; Moscarello, M. A.; Mastronardi, F. G. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system Dis. Models Mech. 2008, 1 (4-5) 229 - 240
140. Moscarello, M. A.; Lei, H.; Mastronardi, F. G.; Winer, S.; Tsui, H.; Li, Z.; Ackerley, C.; Zhang, L.; Raijmakers, R.; Wood, D. D. Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis Dis. Models Mech. 2013, 6 (2) 467 - 78
141. van Boekel, M. A. M.; Vossenaar, E. R.; van den Hoogen, F. H. J.; van Venrooij, W. J. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value Arthritis Res. 2002, 4 (2) 87 - 93
142. Steiner, G.; Smolen, J., Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res. Ther. 2002, 4;.
143. Suzuki, A.; Yamada, R.; Yamamoto, K. Citrullination by peptidylarginine deiminase in rheumatoid arthritis Ann. N.Y. Acad. Sci. 2007, 1108, 323 - 339
144. Wegner, N.; Lundberg, K.; Kinloch, A.; Fisher, B.; Malmstrom, V.; Feldmann, M.; Venables, P. J. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis Immunol. Rev. 2010, 233, 34 - 54
145. Bicker, K. L.; Subramanian, V.; Chumanevich, A. A.; Hofseth, L. J.; Thompson, P. R. Seeing Citrulline: Development of a Phenylglyoxal-Based Probe To Visualize Protein Citrullination J. Am. Chem. Soc. 2012, 134 (41) 17015 - 17018
146. Chen, D. G.; Ma, H.; Hong, H.; Koh, S. S.; Huang, S. M.; Schurter, B. T.; Aswad, D. W.; Stallcup, M. R. Regulation of transcription by a protein methyltransferase Science 1999, 284 (5423) 2174 - 2177
147. Bedford, M. T.; Richard, S. Arginine methylation: an emerging regulator of protein function Mol. Cell 2005, 18 (3) 263 - 272
148. Wysocka, J.; Allis, C. D.; Coonrod, S. Histone arginine methylation and its dynamic regulation Front. Biosci. 2006, 11, 344 - 355
149. Bedford, M. T.; Clarke, S. G. Protein Arginine Methylation in Mammals: Who, What, and Why Mol. Cell 2009, 33 (1) 1 - 13
150. Di Lorenzo, A.; Bedford, M. T. Histone arginine methylation FEBS Lett. 2011, 585 (13) 2024 - 2031
151. Torres-Padilla, M. E.; Parfitt, D. E.; Kouzarides, T.; Zernicka-Goetz, M. Histone arginine methylation regulates pluripotency in the early mouse embryo Nature 2007, 445 (7124) 214 - 218
152. G-Dimethylarginine in Nuclear Protein-Fractions Biochem. Biophys. Res. Commun. 1977, 74 (3) 969 - 976
153. Yang, Y. Z.; Bedford, M. T. Protein arginine methyltransferases and cancer Nat. Rev. Cancer 2013, 13 (1) 37 - 50
154. Cook, J. R.; Lee, J. H.; Yang, Z. H.; Krause, C. D.; Herth, N.; Hoffmann, R.; Pestka, S. FBXO11/PRMT9, a new protein arginine methyltransferase, symmetrically dimethylates arginine residues Biochem. Biophys. Res. Commun. 2006, 342 (2) 472 - 481
155. Krause, C. D.; Yang, Z. H.; Kim, Y. S.; Lee, J. H.; Cook, J. R.; Pestka, S. Protein arginine methyltransferases: evolution and assessment of their pharmacological and therapeutic potential Pharmacol. Ther. 2007, 113 (1) 50 - 87
156. Richon, V. M.; Johnston, D.; Sneeringer, C. J.; Jin, L.; Majer, C. R.; Elliston, K.; Jerva, L. F.; Scott, M. P.; Copeland, R. A. Chemogenetic Analysis of Human Protein Methyltransferases Chem. Biol. Drug Des. 2011, 78 (2) 199 - 210
157. Fielenbach, N.; Guardavaccaro, D.; Neubert, K.; Chan, T.; Li, D. L.; Feng, Q.; Hutter, H.; Pagano, M.; Antebi, A. DRE-1: an evolutionarily conserved F box protein that regulates C-elegans developmental age Dev. Cell 2007, 12 (3) 443 - 455
158. Wang, Y. C.; Li, C. Evolutionarily conserved protein arginine methyltransferases in non-mammalian animal systems FEBS J. 2012, 279 (6) 932 - 45
159. Angyal, S. J.; Warburton, W. K., The Basic Strengths of Methylated Guanidines. J. Chem. Soc. 1951, (Sept), 2492 - 2494.
160. Tripsianes, K.; Madl, T.; Machyna, M.; Fessas, D.; Englbrecht, C.; Fischer, U.; Neugebauer, K. M.; Sattler, M. Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins Nat. Struct. Mol. Biol. 2011, 18 (12) 1414 - U136
161. Kessler, H. Detection of Intramolecular Mobility by NMR Spectroscopy 0.13. Detection of Hindered Rotation and Inversion by NMR Spectroscopy Angew. Chem., Int. Ed. Engl. 1970, 9 (3) 219 - &
162. Liu, H. P.; Wang, J. Y. S.; Huang, Y.; Li, Z. Z.; Gong, W. M.; Lehmann, R.; Xu, R. M. Structural basis for methylarginine-dependent recognition of Aubergine by Tudor Genes Dev. 2010, 24 (17) 1876 - 1881
163. Liu, K.; Chen, C.; Guo, Y. H.; Lam, R.; Bian, C. B.; Xu, C.; Zhao, D. Y.; Jin, J.; MacKenzie, F.; Pawson, T.; Min, J. R. Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (43) 18398 - 18403
164. Tang, J.; Frankel, A.; Cook, R. J.; Kim, S.; Paik, W. K.; Williams, K. R.; Clarke, S.; Herschman, H. R. PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells J. Biol. Chem. 2000, 275 (11) 7723 - 7730
165. Pawlak, M. R.; Scherer, C. A.; Chen, J.; Roshon, M. J.; Ruley, H. E. Arginine N-methyltransferase 1 is required for early postimplantation mouse development, but cells deficient in the enzyme are viable Mol. Cell. Biol. 2000, 20 (13) 4859 - 4869
166. Branscombe, T. L.; Frankel, A.; Lee, J. H.; Cook, J. R.; Yang, Z. H.; Pestka, S.; Clarke, S. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins J. Biol. Chem. 2001, 276 (35) 32971 - 32976
167. G-Monomethylated Arginine Residues J. Biol. Chem. 2012, 287 (11) 7859 - 7870
168. Yang, Y.; Hadjikyriacou, A.; Xia, Z.; Gayatri, S.; Kim, D.; Zurita-Lopez, C.; Kelly, R.; Guo, A.; Li, W.; Clarke, S. G.; Bedford, M. T. PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145 Nat. Commun. 2015, 6, 6428
169. Zobel-Thropp, P.; Gary, J. D.; Clarke, S. δ- N -Methylarginine is a novel posttranslational modification of arginine residues in yeast proteins J. Biol. Chem. 1998, 273 (45) 29283 - 29286
170. Miranda, T. B.; Miranda, M.; Frankel, A.; Clarke, S. PRMT7 is a member of the protein arginine methyltransferase family with a distinct substrate specificity J. Biol. Chem. 2004, 279 (22) 22902 - 22907
171. Zhang, X.; Zhou, L.; Cheng, X. D. Crystal structure of the conserved core of protein arginine methyltransferase PRMT3 EMBO J. 2000, 19 (14) 3509 - 3519
172. Weiss, V. H.; McBride, A. E.; Soriano, M. A.; Filman, D. J.; Silver, P. A.; Hogle, J. M. The structure and oligomerization of the yeast arginine methyltransferase, Hmt1 Nat. Struct. Mol. Biol. 2000, 7 (12) 1165 - 1171
173. Zhang, X.; Cheng, X. D. Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides Structure 2003, 11 (5) 509 - 520
174. Yue, W. W.; Hassler, M.; Roe, S. M.; Thompson-Vale, V.; Pearl, L. H. Insights into histone code syntax from structural and biochemical studies of CARM1 methyltransferase EMBO J. 2007, 26 (20) 4402 - 4412
175. Troffer-Charlier, N.; Cura, V.; Hassenboehler, P.; Moras, D.; Cavarelli, J. Functional insights from structures of coactivator-associated arginine methyltransferase 1 domains EMBO J. 2007, 26 (20) 4391 - 4401
176. Hasegawa, M.; Toma-Fukai, S.; Kim, J. D.; Fukamizu, A.; Shimizu, T. Protein arginine methyltransferase 7 has a novel homodimer-like structure formed by tandem repeats FEBS Lett. 2014, 588 (10) 1942 - 1948
177. Cura, V.; Troffer-Charlier, N.; Wurtz, J. M.; Bonnefond, L.; Cavarelli, J. Structural insight into arginine methylation by the mouse protein arginine methyltransferase 7: a zinc finger freezes the mimic of the dimeric state into a single active site Acta Crystallogr., Sect. D: Biol. Crystallogr. 2014, 70, 2401 - 2412
178. Wang, C. Y.; Zhu, Y. W.; Caceres, T. B.; Liu, L.; Peng, J. H.; Wang, J. C.; Chen, J. J.; Chen, X. W.; Zhang, Z. Y.; Zuo, X. B.; Gong, Q. G.; Teng, M. K.; Hevel, J. M.; Wu, J. H.; Shi, Y. Y. Structural Determinants for the Strict Monomethylation Activity by Trypanosoma brucei Protein Arginine Methyltransferase 7 Structure 2014, 22 (5) 756 - 768
179. Schubert, H. L.; Blumenthal, R. M.; Cheng, X. D. Many paths to methyltransfer: a chronicle of convergence Trends Biochem. Sci. 2003, 28 (6) 329 - 335
180. Cheng, X. D.; Collins, R. E.; Zhang, X. Structural and sequence motifs of protein (histone) methylation enzymes Annu. Rev. Biophys. Biomol. Struct. 2005, 34, 267 - 294
181. Shien, D. M.; Lee, T. Y.; Chang, W. C.; Hsu, J. B. K.; Horng, J. T.; Hsu, P. C.; Wang, T. Y.; Huang, H. D. Incorporating Structural Characteristics for Identification of Protein Methylation Sites J. Comput. Chem. 2009, 30 (9) 1532 - 1543
182. Kolbel, K.; Ihling, C.; Kuhn, U.; Neundorf, I.; Otto, S.; Stichel, J.; Robaa, D.; Beck-Sickinger, A. G.; Sinz, A.; Wahle, E. Peptide Backbone Conformation Affects the Substrate Preference of Protein Arginine Methyltransferase I Biochemistry 2012, 51 (27) 5463 - 5475
183. Antonysamy, S.; Bonday, Z.; Campbell, R. M.; Doyle, B.; Druzina, Z.; Gheyi, T.; Han, B.; Jungheim, L. N.; Qian, Y. W.; Rauch, C.; Russell, M.; Sauder, J. M.; Wasserman, S. R.; Weichert, K.; Willard, F. S.; Zhang, A. P.; Emtage, S. Crystal structure of the human PRMT5:MEP50 complex Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (44) 17960 - 17965
184. Thandapani, P.; O'Connor, T. R.; Bailey, T. L.; Richard, S. Defining the RGG/RG Motif Mol. Cell 2013, 50 (5) 613 - 623
185. Cheng, D. H.; Cote, J.; Shaaban, S.; Bedford, M. T. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing Mol. Cell 2007, 25 (1) 71 - 83
186. Feng, Y.; Maity, R.; Whitelegge, J. P.; Hadjikyriacou, A.; Li, Z. W.; Zurita-Lopez, C.; Al-Hadid, Q.; Clark, A. T.; Bedford, M. T.; Masson, J. Y.; Clarke, S. G. Mammalian Protein Arginine Methyltransferase 7 (PRMT7) Specifically Targets RXR Sites in Lysine- and Arginine-Rich Regions J. Biol. Chem. 2013, 288 (52) 37010 - 37025
187. Wooderchak, W. L.; Zang, T. Z.; Zhou, Z. S.; Acuna, M.; Tahara, S. M.; Hevel, J. M. Substrate profiling of PRMT1 reveals amino acid sequences that extend beyond the "RGG" paradigm Biochemistry 2008, 47 (36) 9456 - 9466
188. Osborne, T. C.; Obianyo, O.; Zhang, X.; Cheng, X.; Thompson, P. R. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis Biochemistry 2007, 46 (46) 13370 - 13381
189. Wang, M.; Fuhrmann, J.; Thompson, P. R. Protein Arginine Methyltransferase 5 Catalyzes Substrate Dimethylation in a Distributive Fashion Biochemistry 2014, 53 (50) 7884 - 7892
190. Lee, D. Y.; Ianculescu, I.; Purcell, D.; Zhang, X.; Cheng, X. D.; Stallcup, M. R. Surface-scanning mutational analysis of protein arginine methyltransferase 1: roles of specific amino acids in methyltransferase substrate specificity, oligomerization, and coactivator function Mol. Endocrinol. 2007, 21 (6) 1381 - 1393
191. Frankel, A.; Yadav, N.; Lee, J. H.; Branscombe, T. L.; Clarke, S.; Bedford, M. T. The novel human protein arginine N-methyltransferase PRMT6 is a nuclear enzyme displaying unique substrate specificity J. Biol. Chem. 2002, 277 (5) 3537 - 3543
192. Gui, S. Y.; Wooderchak-Donahue, W. L.; Zang, T. Z.; Chen, D.; Daly, M. P.; Zhou, Z. S.; Hevel, J. M. Substrate-Induced Control of Product Formation by Protein Arginine Methyltransferase 1 Biochemistry 2013, 52 (1) 199 - 209
193. Burgos, E. S.; Wilczek, C.; Onikubo, T.; Bonanno, J. B.; Jansong, J.; Reimer, U.; Shechter, D. Histone H2A and H4 N-Terminal Tails Are Positioned by the MEP50 WD-Repeat Protein for Efficient Methylation by the PRMT5 Arginine Methyltransferase J. Biol. Chem. 2015, DOI: 10.1074/jbc.M115.636894.
194. Sun, L. T.; Wang, M. Z.; Lv, Z. Y.; Yang, N.; Liu, Y. F.; Bao, S. L.; Gong, W. M.; Xu, R. M. Structural insights into protein arginine symmetric dimethylation by PRMT5 Proc. Natl. Acad. Sci. U.S.A. 2011, 108 (51) 20538 - 20543
195. Gui, S.; Gathiaka, S.; Li, J.; Qu, J.; Acevedo, O.; Hevel, J. M. A remodeled protein arginine methyltransferase 1 (PRMT1) generates symmetric dimethylarginine J. Biol. Chem. 2014, 289 (13) 9320 - 7
196. Wang, M.; Xu, R. M.; Thompson, P. R. Substrate Specificity, Processivity, and Kinetic Mechanism of Protein Arginine Methyltransferase 5 Biochemistry 2013, 52 (32) 5430 - 5440
197. Obianyo, O.; Osborne, T. C.; Thompson, P. R. Kinetic mechanism of protein arginine methyltransferase 1 Biochemistry 2008, 47 (39) 10420 - 10427
198. Obianyo, O.; Thompson, P. R. Kinetic mechanism of protein arginine methyltransferase 6 (PRMT6) J. Biol. Chem. 2012, 287 (8) 6062 - 71
199. Lakowski, T. M.; Frankel, A. A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism J. Biol. Chem. 2008, 283 (15) 10015 - 10025
200. Rust, H. L.; Zurita-Lopez, C. I.; Clarke, S.; Thompson, P. R. Mechanistic Studies on Transcriptional Coactivator Protein Arginine Methyltransferase 1 Biochemistry 2011, 50 (16) 3332 - 3345
201. Zhang, R. H.; Li, X.; Liang, Z. J.; Zhu, K. K.; Lu, J. Y.; Kong, X. Q.; Ouyang, S. S.; Li, L.; Zheng, Y. G.; Luo, C., Theoretical Insights into Catalytic Mechanism of Protein Arginine Methyltransferase 1. PLoS One 2013, 8 (8).
202. Chang, B. S.; Chen, Y.; Zhao, Y. M.; Bruick, R. K. JMJD6 is a histone arginine demethylase Science 2007, 318 (5849) 444 - 447
203. Webby, C. J.; Wolf, A.; Gromak, N.; Dreger, M.; Kramer, H.; Kessler, B.; Nielsen, M. L.; Schmitz, C.; Butler, D. S.; Yates, J. R.; Delahunty, C. M.; Hahn, P.; Lengeling, A.; Mann, M.; Proudfoot, N. J.; Schofield, C. J.; Bottger, A. Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing Science 2009, 325 (5936) 90 - 93
204. Hahn, P.; Wegener, I.; Burrells, A.; Bose, J.; Wolf, A.; Erck, C.; Butler, D.; Schofield, C. J.; Bottger, A.; Lengeling, A., Analysis of Jmjd6 Cellular Localization and Testing for Its Involvement in Histone Demethylation. PLoS One 2010, 5 (10).
205. Metivier, R.; Penot, G.; Hubner, M. R.; Reid, G.; Brand, H.; Kos, M.; Gannon, F. Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter Cell 2003, 115 (6) 751 - 763
206. Le Romancer, M.; Treilleux, I.; Leconte, N.; Robin-Lespinasse, Y.; Sentis, S.; Bouchekioua-Bouzaghou, K.; Goddard, S.; Gobert-Gosse, S.; Corbo, L. Regulation of estrogen rapid signaling through arginine methylation by PRMT1 Mol. Cell 2008, 31 (2) 212 - 221
207. Hou, H. F.; Yu, H. T. Structural insights into histone lysine demethylation Curr. Opin. Struct. Biol. 2010, 20 (6) 739 - 748
208. Shi, Y.; Lan, F.; Matson, C.; Mulligan, P.; Whetstine, J. R.; Cole, P. A.; Casero, R. A.; Shi, Y. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 2004, 119 (7) 941 - 53
209. Tsukada, Y.; Fang, J.; Erdjument-Bromage, H.; Warren, M. E.; Borchers, C. H.; Tempst, P.; Zhang, Y. Histone demethylation by a family of JmjC domain-containing proteins Nature 2006, 439 (7078) 811 - 6
210. Friesen, W. J.; Massenet, S.; Paushkin, S.; Wyce, A.; Dreyfuss, G. SMN, the product of the spinal muscular atrophy gene, binds preferentially to dimethylarginine-containing protein targets Mol. Cell 2001, 7 (5) 1111 - 1117
211. Sprangers, R.; Groves, M. R.; Sinning, L.; Sattler, M. High-resolution X-ray and NMR structures of the SMN tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues J. Mol. Biol. 2003, 327 (2) 507 - 520
212. Cote, J.; Richard, S. Tudor domains bind symmetrical dimethylated arginines J. Biol. Chem. 2005, 280 (31) 28476 - 28483
213. Ma, J. C.; Dougherty, D. A. The cation-π interaction Chem. Rev. (Washington, DC, U.S.) 1997, 97 (5) 1303 - 1324
214. p, and the cold denatured state J. Am. Chem. Soc. 2006, 128 (39) 12735 - 42
215. Hughes, R. M.; Wiggins, K. R.; Khorasanizadeh, S.; Waters, M. L. Recognition of trimethyllysine by a chromodomain is not driven by the hydrophobic effect Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (27) 11184 - 11188
216. Yang, Y. Z.; Lu, Y.; Espejo, A.; Wu, J. C.; Xu, W.; Liang, S. D.; Bedford, M. T. TDRD3 Is an Effector Molecule for Arginine-Methylated Histone Marks Mol. Cell 2010, 40 (6) 1016 - 1023
217. Chen, C.; Nott, T. J.; Jin, J.; Pawson, T. Deciphering arginine methylation: Tudor tells the tale Nat. Rev. Mol. Cell Biol. 2011, 12 (10) 629 - 642
218. Zhao, Q.; Rank, G.; Tan, Y. T.; Li, H. T.; Moritz, R. L.; Simpson, R. J.; Cerruti, L.; Curtis, D. J.; Patel, D. J.; Allis, C. D.; Cunningham, J. M.; Jane, S. M. PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing Nat. Struct. Mol. Biol. 2009, 16 (3) 304 - 311
219. Otani, J.; Nankumo, T.; Arita, K.; Inamoto, S.; Ariyoshi, M.; Shirakawa, M. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain EMBO Rep. 2009, 10 (11) 1235 - 1241
220. Cheng, D.; Yadav, N.; King, R. W.; Swanson, M. S.; Weinstein, E. J.; Bedford, M. T. Small molecule regulators of protein arginine methyltransferases J. Biol. Chem. 2004, 279 (23) 23892 - 9
221. Feng, Y.; Li, M. Y.; Wang, B. H.; Zheng, Y. G. Discovery and Mechanistic Study of a Class of Protein Arginine Methylation Inhibitors J. Med. Chem. 2010, 53 (16) 6028 - 6039
222. Spannhoff, A.; Machmur, R.; Heinke, R.; Trojer, P.; Bauer, I.; Brosch, G.; Schule, R.; Hanefeld, W.; Sippl, W.; Jung, M. A novel arginine methyltransferase inhibitor with cellular activity Bioorg. Med. Chem. Lett. 2007, 17 (15) 4150 - 4153
223. Spannhoff, A.; Heinke, R.; Bauer, I.; Trojer, P.; Metzger, E.; Gust, R.; Schule, R.; Brosch, G.; Sippl, W.; Jung, M. Target-based approach to inhibitors of histone arginine methyltransferases J. Med. Chem. 2007, 50 (10) 2319 - 2325
224. Bissinger, E. M.; Heinke, R.; Spannhoff, A.; Eberlin, A.; Metzger, E.; Cura, V.; Hassenboehler, P.; Cavarelli, J.; Schule, R.; Bedford, M. T.; Sippl, W.; Jung, M. Acyl derivatives of p -aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1 Bioorg. Med. Chem. 2011, 19 (12) 3717 - 3731
225. Osborne, T.; Roska, R. L.; Rajski, S. R.; Thompson, P. R. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1 J. Am. Chem. Soc. 2008, 130 (14) 4574 - 5
226. Weller, R. L.; Rajski, S. R. Design, synthesis, and preliminary biological evaluation of a DNA methyltransferase-directed alkylating agent ChemBioChem 2006, 7 (2) 243 - 5
227. 'T Hart, P.; Lakowski, T. M.; Thomas, D.; Frankel, A.; Martin, N. I. Peptidic Partial Bisubstrates as Inhibitors of the Protein Arginine N-Methyltransferases ChemBioChem 2011, 12 (9) 1427 - 1432
228. Dowden, J.; Hong, W.; Parry, R. V.; Pike, R. A.; Ward, S. G. Toward the development of potent and selective bisubstrate inhibitors of protein arginine methyltransferases Bioorg. Med. Chem. Lett. 2010, 20 (7) 2103 - 5
229. van Haren, M.; van Ufford, L. Q.; Moret, E. E.; Martin, N. I. Synthesis and evaluation of protein arginine N-methyltransferase inhibitors designed to simultaneously occupy both substrate binding sites Org. Biomol. Chem. 2015, 13 (2) 549 - 60
230. Yan, L. L.; Yan, C. L.; Qian, K.; Su, H. R.; Kofsky-Wofford, S. A.; Lee, W. C.; Zhao, X. Y.; Ho, M. C.; Ivanov, I.; Zheng, Y. G. Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1 J. Med. Chem. 2014, 57 (6) 2611 - 2622
231. Obianyo, O.; Causey, C. P.; Osborne, T. C.; Jones, J. E.; Lee, Y. H.; Stallcup, M. R.; Thompson, P. R. A Chloroacetamidine-Based Inactivator of Protein Arginine Methyltransferase 1: Design, Synthesis, and in Vitro and in Vivo Evaluation ChemBioChem 2010, 11 (9) 1219 - 1223
232. Weerapana, E.; Wang, C.; Simon, G. M.; Richter, F.; Khare, S.; Dillon, M. B. D.; Bachovchin, D. A.; Mowen, K.; Baker, D.; Cravatt, B. F. Quantitative reactivity profiling predicts functional cysteines in proteomes Nature 2010, 468 (7325) 790 - U79
233. Rust, H. L. Decoding PRMT1: Studies On the Catalytic Mechanism, Regulation, Inhibition, and Crosstalk of PRMT1-Dependent Methylation. Ph.D. Thesis, University of South Carolina, 2013.
234. Bicker, K. L.; Obianyo, O.; Rust, H. L.; Thompson, P. R. A combinatorial approach to characterize the substrate specificity of protein arginine methyltransferase 1 Mol. BioSyst. 2011, 7 (1) 48 - 51
235. Siarheyeva, A.; Senisterra, G.; Allali-Hassani, A.; Dong, A.; Dobrovetsky, E.; Wasney, G. A.; Chau, I.; Marcellus, R.; Hajian, T.; Liu, F.; Korboukh, I.; Smil, D.; Bolshan, Y.; Min, J.; Wu, H.; Zeng, H.; Loppnau, P.; Poda, G.; Griffin, C.; Aman, A.; Brown, P. J.; Jin, J.; Al-Awar, R.; Arrowsmith, C. H.; Schapira, M.; Vedadi, M. An allosteric inhibitor of protein arginine methyltransferase 3 Structure 2012, 20 (8) 1425 - 35
236. Kaniskan, H. U.; Szewczyk, M. M.; Yu, Z.; Eram, M. S.; Yang, X.; Schmidt, K.; Luo, X.; Dai, M.; He, F.; Zang, I.; Lin, Y.; Kennedy, S.; Li, F.; Dobrovetsky, E.; Dong, A.; Smil, D.; Min, S. J.; Landon, M.; Lin-Jones, J.; Huang, X. P.; Roth, B. L.; Schapira, M.; Atadja, P.; Barsyte-Lovejoy, D.; Arrowsmith, C. H.; Brown, P. J.; Zhao, K.; Jin, J.; Vedadi, M. A Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3) Angew. Chem., Int. Ed. 2015, 54 (17) 5166 - 5170
237. Purandare, A. V.; Chen, Z.; Huynh, T.; Pang, S.; Geng, J.; Vaccaro, W.; Poss, M. A.; Oconnell, J.; Nowak, K.; Jayaraman, L. Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1) Bioorg. Med. Chem. Lett. 2008, 18 (15) 4438 - 4441
238. Wan, H.; Huynh, T.; Pang, S.; Geng, J.; Vaccaro, W.; Poss, M. A.; Trainor, G. L.; Lorenzi, M. V.; Gottardis, M.; Jayaraman, L.; Purandare, A. V. Benzo[ d ]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)-Hit to Lead Studies Bioorg. Med. Chem. Lett. 2009, 19 (17) 5063 - 6
239. Sack, J. S.; Thieffine, S.; Bandiera, T.; Fasolini, M.; Duke, G. J.; Jayaraman, L.; Kish, K. F.; Klei, H. E.; Purandare, A. V.; Rosettani, P.; Troiani, S.; Xie, D. L.; Bertrand, J. A. Structural basis for CARM1 inhibition by indole and pyrazole inhibitors Biochem. J. 2011, 436, 331 - 339
240. Duncan, K. W.; Chesworth, R.; Boriack-Sjodin, P. A.; Jin, L. Methods of inhibiting PRMT5. WO2014100764A2, 2014.
241. Duncan, K. W.; Chesworth, R.; Munchhof, M. J. Preparation of PRMT5 inhibitors useful in the treatment of cancer and metabolic disorder. WO2014100716A1, 2014.
242. Duncan, K. W.; Chesworth, R.; Boriack-Sjodin, P. A.; Munchhof, M. J.; Jin, L. Preparation of N-[3-(3,4-Dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl]arylcarboxamide as PRMT5 inhibitors. WO2014100719A2, 2014.
243. Penebre, E.; Kuplast, K. G.; Majer, C. R.; Johnston, L. D.; Rioux, N.; Munchhof, M.; Jin, L.; Boriak-Sjodin, P. A.; Wigle, T. J.; Jacques, S. L.; West, K. A.; Lingaraj, T.; Stickland, K.; Ribich, S. A.; Raimondi, A.; Porter-Scott, M.; Waters, N. J.; Pollock, R. M.; Smith, J. J.; Barbash, O.; Kruger, R. G.; Copeland, R. A.; Moyer, M. P.; Chesworth, R.; Duncan, K. W. Identification of a First-in-Class PRMT5 Inhibitor with Potent in Vitro and in Vivo Activity in Preclinical Models of Mantle Cell Lymphoma, 56th ASH Annual Meeting; American Society of Hematology: Washington, DC, 2014; p 438.
244. Alinari, L.; Mahasenan, K. V.; Yan, F.; Karkhanis, V.; Chung, J. H.; Smith, E. M.; Quinion, C.; Smith, P. L.; Kim, L.; Patton, J. T.; Lapalombella, R.; Yu, B.; Wu, Y.; Roy, S.; De Leo, A.; Pileri, S.; Agostinelli, C.; Ayers, L.; Bradner, J. E.; Chen-Kiang, S.; Elemento, O.; Motiwala, T.; Majumder, S.; Byrd, J. C.; Jacob, S.; Sif, S.; Li, C.; Baiocchi, R. A. Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation Blood 2015, 125 (16) 2530 - 2543
245. Obianyo, O.; Causey, C. P.; Jones, J. E.; Thompson, P. R. Activity-Based Protein Profiling of Protein Arginine Methyltransferase 1 ACS Chem. Biol. 2011, 6 (10) 1127 - 1135
246. Dillon, M. B. C.; Bachovchin, D. A.; Brown, S. J.; Finn, M. G.; Rosen, H.; Cravatt, B. F.; Mowen, K. A. Novel Inhibitors for PRMT1 Discovered by High-Throughput Screening Using Activity-Based Fluorescence Polarization ACS Chem. Biol. 2012, 7 (7) 1198 - 1204
247. Wang, H. B.; Huang, Z. Q.; Xia, L.; Feng, Q.; Erdjument-Bromage, H.; Strahl, B. D.; Briggs, S. D.; Allis, C. D.; Wong, J. M.; Tempst, P.; Zhang, Y. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor Science 2001, 293 (5531) 853 - 857
248. Tee, W. W.; Pardo, M.; Theunissen, T. W.; Yu, L.; Choudhary, J. S.; Hajkova, P.; Surani, M. A. Prmt5 is essential for early mouse development and acts in the cytoplasm to maintain ES cell pluripotency Genes Dev. 2010, 24 (24) 2772 - 2777
249. Gkountela, S.; Li, Z. W.; Chin, C. J.; Lee, S. A.; Clark, A. T. PRMT5 Is Required for Human Embryonic Stem Cell Proliferation but Not Pluripotency Stem Cell Rev. Rep. 2014, 10 (2) 230 - 239
250. Karkhanis, V.; Wang, L.; Tae, S.; Hu, Y. J.; Imbalzano, A. N.; Sif, S. Protein Arginine Methyltransferase 7 Regulates Cellular Response to DNA Damage by Methylating Promoter Histones H2A and H4 of the Polymerase δ Catalytic Subunit Gene, POLD1 J. Biol. Chem. 2012, 287 (35) 29801 - 29814
251. Waldmann, T.; Izzo, A.; Kamieniarz, K.; Richter, F.; Vogler, C.; Sarg, B.; Lindner, H.; Young, N. L.; Mittler, G.; Garcia, B. A.; Schneider, R., Methylation of H2AR29 is a novel repressive PRMT6 target. Epigenet. Chromatin 2011, 4.
252. Iberg, A. N.; Espejo, A.; Cheng, D.; Kim, D.; Michaud-Levesque, J.; Richard, S.; Bedford, M. T. Arginine methylation of the histone H3 tail impedes effector binding J. Biol. Chem. 2008, 283 (6) 3006 - 3010
253. Tsai, W. W.; Niessen, S.; Goebel, N.; Yates, J. R.; Guccione, E.; Montminy, M. PRMT5 modulates the metabolic response to fasting signals Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (22) 8870 - 8875
254. Wang, S. C. M.; Dowhan, D. H.; Eriksson, N. A.; Muscat, G. E. O. CARM1/PRMT4 is necessary for the glycogen gene expression programme in skeletal muscle cells Biochem. J. 2012, 444, 323 - 331
255. LeBlanc, S. E.; Konda, S.; Wu, Q.; Hu, Y. J.; Oslowski, C. M.; Sif, S.; Imbalzano, A. N. Protein arginine methyltransferase 5 (Prmt5) promotes gene expression of peroxisome proliferator-activated receptor γ2 (PPARγ2) and its target genes during adipogenesis Mol. Endocrinol. 2012, 26 (4) 583 - 97
256. Wu, J.; Cui, N.; Wang, R.; Li, J. W.; Wong, J. M., A Role for CARM1-Mediated Histone H3 Arginine Methylation in Protecting Histone Acetylation by Releasing Corepressors from Chromatin. PLoS One 2012, 7 (6).
257. Wu, Q.; Bruce, A. W.; Jedrusik, A.; Ellis, P. D.; Andrews, R. M.; Langford, C. F.; Glover, D. M.; Zernicka-Goetz, M. CARM1 Is Required in Embryonic Stem Cells To Maintain Pluripotency and Resist Differentiation Stem Cells 2009, 27 (11) 2637 - 2645
258. Chen, S. L.; Loffler, K. A.; Chen, D. G.; Stallcup, M. R.; Muscat, G. E. O. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation-CARM1 coactivates myocyte enhancer factor-2 J. Biol. Chem. 2002, 277 (6) 4324 - 4333
259. Cheung, N.; Chan, L. C.; Thompson, A.; Cleary, M. L.; So, C. W. E. Protein arginine-methyltransferase-dependent oncogenesis Nat. Cell Biol. 2007, 9 (10) 1208 - 1215
260. Pal, S.; Yun, R.; Datta, A.; Lacomis, L.; Erdjument-Bromage, H.; Kumar, J.; Tempst, P.; Sif, S. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad Mol. Cell. Biol. 2003, 23 (21) 7475 - 7487
261. Xu, X. J.; Hoang, S.; Mayo, M. W.; Bekiranov, S., Application of machine learning methods to histone methylation ChIP-Seq data reveals H4R3me2 globally represses gene expression. BMC Bioinf. 2010, 11.
262. Li, J. J.; Zhou, F.; Zhan, D. G.; Gao, Q. Q.; Cui, N.; Li, J. W.; Iakhiaeva, E.; Zwieb, C.; Lin, B. Y.; Wong, J. M. A Novel Histone H4 Arginine 3 Methylation-Sensitive Histone H4 Binding Activity and Transcriptional Regulatory Function for Signal Recognition Particle Subunits SRP68 and SRP72 J. Biol. Chem. 2012, 287 (48) 40641 - 40651
263. Guendel, I.; Carpio, L.; Pedati, C.; Schwartz, A.; Teal, C.; Kashanchi, F.; Kehn-Hall, K., Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function. PLoS One 2010, 5 (6).
264. Dormann, D.; Madl, T.; Valori, C. F.; Bentmann, E.; Tahirovic, S.; Abou-Ajram, C.; Kremmer, E.; Ansorge, O.; Mackenzie, I. R. A.; Neumann, M.; Haass, C. Arginine methylation next to the PY-NLS modulates Transportin binding and nuclear import of FUS EMBO J. 2012, 31 (22) 4258 - 4275
265. Jansson, M.; Durant, S. T.; Cho, E. C.; Sheahan, S.; Edelmann, M.; Kessler, B.; La Thangue, N. B. Arginine methylation regulates the p53 response Nat. Cell Biol. 2008, 10 (12) 1431 - U122
266. Scoumanne, A.; Zhang, J.; Chen, X. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function Nucleic Acids Res. 2009, 37 (15) 4965 - 4976
267. Mathioudaki, K.; Scorilas, A.; Ardavanis, A.; Lymberi, P.; Tsiambas, E.; Devetzi, M.; Apostolaki, A.; Talieri, M. Clinical evaluation of PRMT1 gene expression in breast cancer Tumor Biol. 2011, 32 (3) 575 - 582
268. Baldwin, R. M.; Morettin, A.; Paris, G.; Goulet, I.; Cote, J. Alternatively spliced protein arginine methyltransferase 1 isoform PRMT1v2 promotes the survival and invasiveness of breast cancer cells Cell Cycle 2012, 11 (24) 4597 - 4612
269. Zhong, J.; Cao, R. X.; Hong, T.; Yang, J.; Zu, X. Y.; Xiao, X. H.; Liu, J. H.; Wen, G. B. Identification and expression analysis of a novel transcript of the human PRMT2 gene resulted from alternative polyadenylation in breast cancer Gene 2011, 487 (1) 1 - 9
270. Singh, V.; Miranda, T. B.; Jiang, W.; Frankel, A.; Roemer, M. E.; Robb, V. A.; Gutmann, D. H.; Herschman, H. R.; Clarke, S.; Newsham, I. F. DAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivo Oncogene 2004, 23 (47) 7761 - 7771
271. Kim, Y. R.; Lee, B. K.; Park, R. Y.; Nguyen, N. T. X.; Bae, J. A.; Kwon, D. D.; Jung, C. Differential CARM1 expression in prostate and colorectal cancers. BMC Cancer 2010, 10, No. 197.
272. Hong, H.; Kao, C. H.; Jeng, M. H.; Eble, J. N.; Koch, M. O.; Gardner, T. A.; Zhang, S. B.; Li, L.; Pan, C. X.; Hu, Z. Q.; MacLennan, G. T.; Cheng, L. Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status Cancer 2004, 101 (1) 83 - 89
273. Al-Dhaheri, M.; Wu, J. C.; Skliris, G. P.; Li, J.; Higashimato, K.; Wang, Y. D.; White, K. P.; Lambert, P.; Zhu, Y. R.; Murphy, L.; Xu, W. CARM1 Is an Important Determinant of ERα-Dependent Breast Cancer Cell Differentiation and Proliferation in Breast Cancer Cells Cancer Res. 2011, 71 (6) 2118 - 2128
274. Yadav, N.; Lee, J.; Kim, J.; Shen, J.; Hu, M. C.; Aldaz, C. M.; Bedford, M. T. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (11) 6464 - 8
275. El Messaoudi, S.; Fabbrizio, E.; Rodriguez, C.; Chuchana, P.; Fauquier, L.; Cheng, D. H.; Theillet, C.; Vandel, L.; Bedford, M. T.; Sardet, C. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene Proc. Natl. Acad. Sci. U.S.A. 2006, 103 (36) 13351 - 13356
276. Covic, M.; Hassa, P. O.; Saccani, S.; Buerki, C.; Meier, N. I.; Lombardi, C.; Imhof, R.; Bedford, M. T.; Natoli, G.; Hottiger, M. O. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-κB-dependent gene expression EMBO J. 2005, 24 (1) 85 - 96
277. Wang, L.; Pal, S.; Sif, S. Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells Mol. Cell. Biol. 2008, 28 (20) 6262 - 6277
278. Wei, H.; Wang, B. L.; Miyagi, M.; She, Y.; Gopalan, B.; Huang, D. B.; Ghosh, G.; Stark, G. R.; Lu, T. PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB Proc. Natl. Acad. Sci. U.S.A. 2013, 110 (33) 13516 - 13521
279. Shilo, K.; Wu, X.; Sharma, S.; Welliver, M.; Duan, W. R.; Villalona-Calero, M.; Fukuoka, J.; Sif, S.; Baiocchi, R.; Hitchcock, C. L.; Zhao, W. Q.; Otterson, G. A. Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors. Diagn. Pathol. 2013, 8, No. 201.
280. Yan, F. T.; Alinari, L.; Lustberg, M. E.; Martin, L. K.; Cordero-Nieves, H. M.; Banasavadi-Siddegowda, Y.; Virk, S.; Barnholtz-Sloan, J.; Bell, E. H.; Wojton, J.; Jacob, N. K.; Chakravarti, A.; Nowicki, M. O.; Wu, X.; Lapalombella, R.; Datta, J.; Yu, B.; Gordon, K.; Haseley, A.; Patton, J. T.; Smith, P. L.; Ryu, J.; Zhang, X. L.; Mo, X. K.; Marcucci, G.; Nuovo, G.; Kwon, C. H.; Byrd, J. C.; Chiocca, E. A.; Li, C. L.; Sif, S.; Jacob, S.; Lawler, S.; Kaur, B.; Baiocchi, R. A. Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma Cancer Res. 2014, 74 (6) 1752 - 1765
281. Pal, S.; Vishwanath, S. N.; Erdjument-Bromage, H.; Tempst, P.; Sif, S. Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes Mol. Cell. Biol. 2004, 24 (21) 9630 - 9645
282. Boger, R. H.; Vallance, P.; Cooke, J. P. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase Atheroscler. Suppl. 2003, 4 (4) 1 - 3
283. Pou, S.; Keaton, L.; Surichamorn, W.; Rosen, G. M. Mechanism of superoxide generation by neuronal nitric-oxide synthase J. Biol. Chem. 1999, 274 (14) 9573 - 9580
284. Jacobi, J.; Tsao, P. S. Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? Am. J. Nephrol. 2008, 28 (2) 224 - 237
285. 2+-calmodulin-dependent phosphorylation of arginine in histone 3 by a nuclear kinase from mouse leukemia cells J. Biol. Chem. 1994, 269 (4) 2722 - 7
286. Fuhrmann, J.; Schmidt, A.; Spiess, S.; Lehner, A.; Turgay, K.; Mechtler, K.; Charpentier, E.; Clausen, T. McsB Is a Protein Arginine Kinase That Phosphorylates and Inhibits the Heat-Shock Regulator CtsR Science 2009, 324 (5932) 1323 - 1327
287. Slade, D. J.; Subramanian, V.; Fuhrmann, J.; Thompson, P. R. Chemical and Biological Methods To Detect Post-Translational Modifications of Arginine Biopolymers 2014, 101 (2) 133 - 143
288. Ellington, W. R. Evolution and physiological roles of phosphagen systems Annu. Rev. Physiol. 2001, 63, 289 - 325
289. Blethen, S. L. Kinetic Properties of Arginine Kinase Isoenzymes of Limulus Polyphemus Arch. Biochem. Biophys. 1972, 149 (1) 244 - &
290. Zhou, G. F.; Somasundaram, T.; Blanc, E.; Parthasarathy, G.; Ellington, W. R.; Chapman, M. S. Transition state structure of arginine kinase: implications for catalysis of bimolecular reactions Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (15) 8449 - 8454
291. Pruett, P. S.; Azzi, A.; Clark, S. A.; Yousef, M. S.; Gattis, J. L.; Somasundaram, T.; Ellington, W. R.; Chapman, M. S. The putative catalytic bases have, at most, an accessory role in the mechanism of arginine kinase J. Biol. Chem. 2003, 278 (29) 26952 - 26957
292. Fuhrmann, J.; Mierzwa, B.; Trentini, D. B.; Spiess, S.; Lehner, A.; Charpentier, E.; Clausen, T. Structural Basis for Recognizing Phosphoarginine and Evolving Residue-Specific Protein Phosphatases in Gram-Positive Bacteria Cell Rep. 2013, 3 (6) 1832 - 1839
293. Elsholz, A. K. W.; Turgay, K.; Michalik, S.; Hessling, B.; Gronau, K.; Oertel, D.; Mader, U.; Bernhardt, J.; Becher, D.; Hecker, M.; Gerth, U. Global impact of protein arginine phosphorylation on the physiology of Bacillus subtilis Proc. Natl. Acad. Sci. U.S.A. 2012, 109 (19) 7451 - 7456
294. Fuhrmann, J.; Subramanian, V.; Thompson, P. R. Targeting the Arginine Phosphatase YwIE with a Catalytic Redox-Based Inhibitor ACS Chem. Biol. 2013, 8 (9) 2024 - 2032
295. 2+-calmodulin-activated histone 3 arginine kinase in quiescent rat heart endothelial cells compared to actively dividing cells J. Biol. Chem. 1995, 270 (39) 23155 - 8
296. Schmidt, A.; Ammerer, G.; Mechtler, K. Studying the fragmentation behavior of peptides with arginine phosphorylation and its influence on phospho-site localization Proteomics 2013, 13 (6) 945 - 954
297. Glowacki, G.; Braren, R.; Firner, K.; Nissen, M.; Kuhl, M.; Reche, P.; Bazan, F.; Cetkovic-Cvrlje, M.; Leiter, E.; Haag, F.; Koch-Nolte, F. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse Protein Sci. 2002, 11 (7) 1657 - 1670
298. Hottiger, M. O. ADP-ribosylation of histones by ARTD1: an additional module of the histone code? FEBS Lett. 2011, 585 (11) 1595 - 1599
299. Smith, S. The world according to PARP Trends Biochem. Sci. 2001, 26 (3) 174 - 179
300. Frye, R. A. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity Biochem. Biophys. Res. Commun. 1999, 260 (1) 273 - 279
301. Hawse, W. F.; Wolberger, C. Structure-Based Mechanism of ADP-Ribosylation by Sirtuins J. Biol. Chem. 2009, 284 (48) 33654 - 33661
302. Moss, J.; Stanley, S. J.; Nightingale, M. S.; Murtagh, J. J.; Monaco, L.; Mishima, K.; Chen, H. C.; Williamson, K. C.; Tsai, S. C. Molecular and Immunological Characterization of Adp-Ribosylarginine Hydrolases J. Biol. Chem. 1992, 267 (15) 10481 - 10488
303. Stone, P. R.; Lorimer, W. S.; Kidwell, W. R. Properties of Complex between Histone H-1 and Poly(Adp-Ribose) Synthesized in Hela-Cell Nuclei Eur. J. Biochem. 1977, 81 (1) 9 - 18
304. Burzio, L. O.; Riquelme, P. T.; Koide, S. S. Adp Ribosylation of Rat-Liver Nucleosomal Core Histones J. Biol. Chem. 1979, 254 (8) 3029 - 3037
305. Golderer, G.; Grobner, P. Adp-Ribosylation of Core Histones and Their Acetylated Subspecies Biochem. J. 1991, 277, 607 - 610
306. Wong, C. C. L.; Xu, T.; Rai, R.; Bailey, A. O.; Yates, J. R.; Wolf, Y. I.; Zebroski, H.; Kashina, A. Global analysis of posttranslational protein arginylation PLoS Biol. 2007, 5 (10) 2231 - 2242
307. Saha, S.; Wong, C. C. L.; Xu, T.; Namgoong, S.; Zebroski, H.; Yates, J. R.; Kashina, A. Arginylation and Methylation Double Up To Regulate Nuclear Proteins and Nuclear Architecture in Vivo Chem. Biol. 2011, 18 (11) 1369 - 1378
308. Balzi, E.; Choder, M.; Chen, W. N.; Varshavsky, A.; Goffeau, A. Cloning and Functional-Analysis of the Arginyl-Transfer RNA-Protein Transferase Gene Ate1 of Saccharomyces cerevisiae J. Biol. Chem. 1990, 265 (13) 7464 - 7471
309. Bachmair, A.; Finley, D.; Varshavsky, A. In Vivo Half-Life of a Protein Is a Function of Its Amino-Terminal Residue Science 1986, 234 (4773) 179 - 186
310. Lee, M. J.; Tasaki, T.; Moroi, K.; An, J. Y.; Kimura, S.; Davydov, I. V.; Kwon, Y. T. RGS4 and RGS5 are in vivo substrates of the N-end rule pathway Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (42) 15030 - 15035
311. Hu, R. G.; Sheng, J.; Qi, X.; Xu, Z. M.; Takahashi, T. T.; Varshavsky, A. The N-end rule pathway as a nitric oxide sensor controlling the levels of multiple regulators Nature 2005, 437 (7061) 981 - 986
312. Kaneko, T.; Huang, H. M.; Cao, X.; Li, X.; Li, C. J.; Voss, C.; Sidhu, S. S.; Li, S. S. C. Superbinder SH2 Domains Act as Antagonists of Cell Signaling Sci. Signaling 2012, 5 (243) ra68
313. Emamzadah, S.; Tropia, L.; Halazonetis, T. D. Crystal Structure of a Multidomain Human p53 Tetramer Bound to the Natural CDKN1A (p21) p53-Response Element Mol. Cancer Res. 2011, 9 (11) 1493 - 1499
314. Sievers, F.; Wilm, A.; Dineen, D.; Gibson, T. J.; Karplus, K.; Li, W. Z.; Lopez, R.; McWilliam, H.; Remmert, M.; Soding, J.; Thompson, J. D.; Higgins, D. G., Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 2011, 7;.
315. Robert, X.; Gouet, P. Deciphering key features in protein structures with the new ENDscript server Nucleic Acids Res. 2014, 42 (W1) W320 - W324
316. Yang, M. J.; Culhane, J. C.; Szewczuk, L. M.; Gocke, C. B.; Brautigam, C. A.; Tomchick, D. R.; Machius, M.; Cole, P. A.; Yu, H. T. Structural basis of histone demethylation by LSD1 revealed by suicide inactivation Nat. Struct. Mol. Biol. 2007, 14 (6) 535 - 539
317. Ng, S. S.; Kavanagh, K. L.; McDonough, M. A.; Butler, D.; Pilka, E. S.; Lienard, B. M. R.; Bray, J. E.; Savitsky, P.; Gileadi, O.; von Delft, F.; Rose, N. R.; Offer, J.; Scheinost, J. C.; Borowski, T.; Sundstrom, M.; Schofield, C. J.; Oppermann, U. Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity Nature 2007, 448 (7149) 87 - 91